Skip to main content
Caplight Logo









EpiCypher

EpiCypher

Private
Durham, North CarolinaHealthcare & Life Scienceshttps://www.epicypher.com/

Last Round

Seed

Jul 1, 2024

Total Funding Raised

$9.11M

Company Overview

EpiCypher is a biotechnology company that develops and sells reagents, kits, and services for epigenetics and chromatin biology research.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Biotech Equipment, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts, Services & Consulting

AI Layer

Non-AI

Keywords

CUT&RUNCUT&Tagdesigner nucleosomeschromatin mappingepigenetics toolsepigenomicsChIP-seq alternativelow input epigenomicsmultiomic profilingepigenetics drug discoveryFiber-seqhistone modification analysisepigenetics servicesDNA methylation analysisantibody validationspike-in controlsbioinformatics platform

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

EpiCypher Comparables

Compare EpiCypher with similar companies based on industry and business-model similarity.

EpiCypher comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Active Motif
85%
Epigentek Group Inc.
79%
Hologic, Inc.
78%

EpiCypher Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJul 1, 2024
GrantAug 18, 2022
AcceleratorOct 15, 2021
GrantMay 6, 2014

EpiCypher Investors

Notable investors and investment history

EpiCypher investors
InvestorRounds
NIH RADxGrant
BioTools InnovatorAccelerator
BroadOak Capital PartnersSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 1, 2026

    Monthly visitors increased 43% MoM, reaching 32.6K.

  • Oct 27, 2024

    Monthly visitors increased 37% MoM to 23.3K.

EpiCypher Filings

Explore SEC and related filing metadata, where available.

EpiCypher filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about EpiCypher's valuation, stock price, and market status.

Is EpiCypher a public or private company?

EpiCypher is a private company.

What is the current stock price of EpiCypher?

EpiCypher is a private company with no public stock price. No recent secondary market data is available.

How much is EpiCypher worth (valuation)?

Valuation information for EpiCypher is not publicly available.

Can I buy EpiCypher stock?

EpiCypher shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was EpiCypher's last funding round?

EpiCypher's most recent funding round was Seed on July 1, 2024.

Who are the main investors in EpiCypher?

Key investors in EpiCypher include NIH RADx, BioTools Innovator, BroadOak Capital Partners.

Will EpiCypher IPO soon?

No public IPO plans have been announced for EpiCypher.

How can I track EpiCypher secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor EpiCypher's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersDurham, North Carolina
Employee Range46
Year Founded2012
Last FundingJul 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?